SKB107 Wins China NMPA Nod for Bone Metastases The...
Category : Approval/Launch 29 March 2025Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd, a holding subsidiary of Kelun Pharmaceutical, whic...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Bayer, Puhe BioPharma Ink Global License Agreement...
Category : Licensing/Collaboration Deal 29 March 2025Bayer and Suzhou Puhe BioPharma Co.,Ltd., a clinical-stage biotechnology company, announced that the...
US FDA grants fast track designation to Sanofi’s m...
Category : ODD/BTA/FTA Status 29 March 2025The US Food and Drug Administration (FDA) has granted fast track designation to Sanofi’s mRNA...
IASO Bio Secures NDA Approval on Equecabtagene Aut...
Category : Approval/Launch 29 March 2025IASO Biotherapeutics has received approval from the Pharmaceutical Administration Bureau of the Maca...
Merck Signs $2B Deal with Hengrui Pharma for Cardi...
Category : Licensing/Collaboration Deal 28 March 2025For an investigational oral ipoprotein(a) inhibitor for cardiovascular disease Merck, known as MSD o...
Latest Newsletter Post
-
IASO Bio Secures NDA Approval on Eq..
29 March 2025
-
US FDA grants fast track designatio..
29 March 2025
-
Bayer, Puhe BioPharma Ink Global Li..
29 March 2025
-
SKB107 Wins China NMPA Nod for Bone..
29 March 2025
-
AdjuTec Pharma, Venus Remedies Part..
28 March 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com